MA-EXCEL-DRYER
After an exhaustive two-year process, a University of Arizona Health Sciences research team have announced the publication of their work, Comparison of electric hand dryers and paper towels for hand hygiene: a critical review of the literature . The review culled the current breadth of data, including published studies, news reports and online content, seeking to uncover which hand drying method, hand dryers or paper towels, is more hygienic and safer relative to human health risks. The researchers found that, while studies in the public arena generally favor paper towels over hand dryers, the conclusions are largely misleading and unsubstantiated.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200910005927/en/
Through the scientific research, the use of hand dryers and paper towels to dry hands were found to be equal from a health and safety perspective; the findings echo recommendations from the World Health Organization that everyone “frequently clean [their] hands…” and “dry [them] thoroughly by using paper towels or a warm air dryer,” and the Centers for Disease Control and Prevention that report that, “Both [clean towels or air hand dryers] are effective ways to dry hands.”
To conduct the study, the research team considered 293 papers and published studies for inclusion in their review, rejecting 270 for failing to meet review criteria or for reporting generalized recommendations without sufficient scientific evidence. The 23 peer-reviewed studies that met the inclusion criteria were categorized and prioritized based on their scientific rigor, a score determined by taking into account such factors as sample size, methodology, data quality and whether or not the study was set up to represent real-world scenarios.
The study that was found to have the highest rigor score was an independent study conducted by the Mayo Clinic, Effects of 4 Hand-Drying Methods for Removing Bacteria From Washed Hands: A Randomized Trial . It found that “…there is no difference in bacteria counts when drying with paper towels or hand dryers.” Only three studies received positive rigor scores for having realistic testing conditions, and none of the studies reported any negative effects of either hand drying method on human health.
Although numerous studies have been published evaluating the “best” method for hand drying, “best” has been defined in a variety of ways relative to bacterial removal efficacy, environmental contamination potentials, ecological or cost benefits, noise and more. Kelly Reynolds, MSPH, Ph.D., the corresponding author of the review explained that, “No study to date has examined the “best” drying method,” and that she and her team, “found no empirical data to support one hand drying method over another from a health and safety perspective.”
In light of the coronavirus pandemic, hand hygiene has been widely covered in the media. Reynolds shared that, “Media reports frequently used sensationalized headlines. While such headlines may increase traffic, they sometimes overgeneralize or exaggerate research results. Consumers may only read the headlines which can influence public opinion toward biased or erroneous conclusions.”
“At a time when proper hand washing and drying is of the utmost importance, exclusively recommending paper towels is limiting, and frankly, irresponsible,” said William Gagnon, vice president of marketing and sales at Excel Dryer. “Hand dryers provide an effective way to achieve completely dry hands, a critical part of proper hand hygiene, the top defense against the spread of germs, like coronavirus.”
The scoping review’s conclusion calls for future studies to examine the relationship between contamination that occurs due to hand-drying methods and human health outcomes. They offer that this can be accomplished by utilizing real-world scenarios while controlling certain variables.
“We hope these credible findings will be consulted as part of guidelines and reopening plans,” said William Gagnon, vice president of marketing and sales at Excel Dryer. “Sensationalized news accounts and click-bait headlines created an unsubstantiated concern around hand dryers and hygiene. We’re grateful to the researchers for uncovering the truth, and hope the findings will help to dispel myths and categorize hand dryers as the hygienic hand drying solution they are.”
About Excel Dryer, Inc.
Excel Dryer has been manufacturing the finest American-made hand dryers for more than 50 years. The family-owned and -operated company revolutionized the industry with the invention of the patented XLERATOR® Hand Dryer that created the high-speed, energy-efficient hand dryer category and set a new standard for performance, reliability and customer satisfaction. Excel Dryer prides itself on offering the best customer service and making hygienic, cost-effective and sustainable products people can depend on. Available for distribution worldwide, Excel Dryer products can be purchased through an established network of sales representatives who call on more than 5,000 distributors globally. Learn more about Excel Dryer at exceldryer.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200910005927/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
